10-Q Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643 Q3 2015

Filing Information

Form Type	10-Q
Accession Number	`0001213900-15-003882`
Period End Date	20150331
Filing Date	20150515
Fiscal Year	2015
Fiscal Period	Q3
XBRL Instance	relm-20150331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 59 Income Statement 44 Cash Flow Statement 70

Balance Sheet 59 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$26.96M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$25.56M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.52M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.56M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.46M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$178.16K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$857.96K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$27.81M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$25.74M	USD	Point-in-time
Fixed assets, net	`PropertyPlantAndEquipmentNet`	$23.35K	USD	Point-in-time
Fixed assets, net	`PropertyPlantAndEquipmentNet`	$9.84K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	40.29M	shares	Point-in-time
Security deposit	`OtherAssets`	$12.10K	USD	Point-in-time
Security deposit	`OtherAssets`	$12.10K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	53.74M	shares	Point-in-time
Total assets	`Assets`	$27.85M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	40.29M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	53.74M	shares	Point-in-time
Total assets	`Assets`	$25.76M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$390.37K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$746.10K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$398.49K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$382.02K	USD	Point-in-time
Note payable	`NotesPayableCurrent`	-	USD	Point-in-time
Note payable	`NotesPayableCurrent`	$58.36K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$24.47M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$25.59M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$25.26M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$26.77M	USD	Point-in-time
Long-term liability - accrued expense	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$100.00K	USD	Point-in-time
Long-term liability - accrued expense	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$100.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$25.36M	USD	Point-in-time
Total liabilities	`Liabilities`	$26.87M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, value	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, value	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value per share, 500,000,000 shares authorized, 53,735,211 shares and 40,294,217 shares issued and outstanding, respectively	`CommonStockValue`	$40.29K	USD	Point-in-time
Common stock, $0.001 par value per share, 500,000,000 shares authorized, 53,735,211 shares and 40,294,217 shares issued and outstanding, respectively	`CommonStockValue`	$53.73K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$84.60M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$54.17M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-82.16M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-55.32M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-1.11M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$2.49M	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$27.85M	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$25.76M	USD	Point-in-time

Income Statement 44 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$-5.01M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$-215.79K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$-2.27M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$-4.76M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$-2.29M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$-1.49M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$-496.10K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$-7.67M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$-6.25M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$-711.90K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$-4.57M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$-12.68M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-12.68M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-711.90K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-6.25M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-4.57M	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$6.31M	USD	3 Qtrs
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$7.33M	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$2.10M	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$-14.18M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$2.43K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	-	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	-	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$9.65K	USD	3 Qtrs
Interest expense	`InterestExpense`	$123.80K	USD	1 Quarter
Interest expense	`InterestExpense`	$4.49K	USD	3 Qtrs
Interest expense	`InterestExpense`	$125.00	USD	1 Quarter
Interest expense	`InterestExpense`	$302.44K	USD	3 Qtrs
Total other income (expenses)	`NonoperatingIncomeExpense`	$7.21M	USD	1 Quarter
Total other income (expenses)	`NonoperatingIncomeExpense`	$-14.17M	USD	3 Qtrs
Total other income (expenses)	`NonoperatingIncomeExpense`	$2.10M	USD	1 Quarter
Total other income (expenses)	`NonoperatingIncomeExpense`	$6.01M	USD	3 Qtrs
Net Income (Loss)	`NetIncomeLoss`	$6.49M	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$-26.85M	USD	3 Qtrs
Net Income (Loss)	`NetIncomeLoss`	$-2.46M	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$-238.21K	USD	3 Qtrs
Net Income (Loss) per common share - basic	`EarningsPerShareBasic`	$-0.10	USD	3 Qtrs
Net Income (Loss) per common share - basic	`EarningsPerShareBasic`	$1.98	USD	1 Quarter
Net Income (Loss) per common share - basic	`EarningsPerShareBasic`	$-0.05	USD	1 Quarter
Net Income (Loss) per common share - basic	`EarningsPerShareBasic`	$-0.56	USD	3 Qtrs
Net Income (Loss) per common share - diluted	`EarningsPerShareDiluted`	$-0.10	USD	3 Qtrs
Net Income (Loss) per common share - diluted	`EarningsPerShareDiluted`	$0.42	USD	1 Quarter
Net Income (Loss) per common share - diluted	`EarningsPerShareDiluted`	$-0.05	USD	1 Quarter
Net Income (Loss) per common share - diluted	`EarningsPerShareDiluted`	$-0.56	USD	3 Qtrs

Cash Flow Statement 70 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$6.49M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-26.85M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.46M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-238.21K	USD	3 Qtrs
Depreciation expense	`Depreciation`	$5.95K	USD	3 Qtrs
Depreciation expense	`Depreciation`	$373.00	USD	3 Qtrs
Common stock issued for services	`CommonStockIssuedForServices`	$-3.78M	USD	3 Qtrs
Common stock issued for services	`CommonStockIssuedForServices`	$-1.11M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$447.78K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$600.08K	USD	3 Qtrs
Change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$-6.31M	USD	3 Qtrs
Change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$14.18M	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	-	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$172.82K	USD	3 Qtrs
Amortization of deferred financing costs	`AmortizationOfFinancingCosts`	$65.76K	USD	3 Qtrs
Amortization of deferred financing costs	`AmortizationOfFinancingCosts`	-	USD	3 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$31.32K	USD	3 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$444.53K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-355.73K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$24.98K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$248.84K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$16.47K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.85M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-11.74M	USD	3 Qtrs
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$9.47K	USD	3 Qtrs
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$19.46K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-9.47K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-19.46K	USD	3 Qtrs
Net proceeds from the exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	3 Qtrs
Net proceeds from the exercise of warrants	`ProceedsFromWarrantExercises`	$13.44M	USD	3 Qtrs
Principal payments of note payable	`RepaymentsOfNotesPayable`	-	USD	3 Qtrs
Principal payments of note payable	`RepaymentsOfNotesPayable`	$293.63K	USD	3 Qtrs
Proceeds from sale of Series A preferred stock and warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	-	USD	3 Qtrs
Proceeds from sale of Series A preferred stock and warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	$2.30M	USD	3 Qtrs
Proceeds from subordinated promissory notes payable, net of financing costs	`ProceedsFromSubordinatedPromissoryNotesNetOfDeferredFinancingCosts`	-	USD	3 Qtrs
Proceeds from subordinated promissory notes payable, net of financing costs	`ProceedsFromSubordinatedPromissoryNotesNetOfDeferredFinancingCosts`	$501.60K	USD	3 Qtrs
Payment of deferred offering costs	`PaymentOfDeferredOfferingCosts`	$-45.50K	USD	3 Qtrs
Payment of deferred offering costs	`PaymentOfDeferredOfferingCosts`	-	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.76M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$13.15M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashPeriodIncreaseDecrease`	$1.39M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashPeriodIncreaseDecrease`	$899.40K	USD	3 Qtrs
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$26.96M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$25.56M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$3.52M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$1.56M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$2.46M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$26.96M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$25.56M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$3.52M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$1.56M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$2.46M	USD	Point-in-time
Income taxes	`IncomeTaxesPaidNet`	-	USD	3 Qtrs
Income taxes	`IncomeTaxesPaidNet`	-	USD	3 Qtrs
Interest	`InterestPaid`	-	USD	3 Qtrs
Interest	`InterestPaid`	$4.49K	USD	3 Qtrs
Financing of insurance premiums by issuance of note payable	`FinancingOfNotePayable`	$293.62K	USD	3 Qtrs
Cancellation of note payable for insurance premiums	`CancellationOfNotePayable`	$55.22K	USD	3 Qtrs
Reclassification of warrant liabilities to additional paid-in capital for warrant exercises	`FairValueAdjustmentOfWarrants`	-	USD	3 Qtrs
Reclassification of warrant liabilities to additional paid-in capital for warrant exercises	`FairValueAdjustmentOfWarrants`	$15.30M	USD	3 Qtrs
Conversion of Series A preferred stock to common stock	`ConversionOfSeriesAPreferredStockToCommonStock`	-	USD	3 Qtrs
Conversion of Series A preferred stock to common stock	`ConversionOfSeriesAPreferredStockToCommonStock`	$2.87K	USD	3 Qtrs
Fair value of derivatives issued in connection with issuance of Series A preferred stock	`FairValueOfDerivativesIssuedInConnectionWithIssuanceOfPreferredStock`	-	USD	3 Qtrs
Fair value of derivatives issued in connection with issuance of Series A preferred stock	`FairValueOfDerivativesIssuedInConnectionWithIssuanceOfPreferredStock`	$1.16M	USD	3 Qtrs
Fair value of derivative warrants issued to lenders in connection with issuance of subordinated promissory notes	`FairValueOfDerivativeWarrantsIssuedToLendersInConnectionWithIssuanceOfSubordinatedPromissoryNotes`	-	USD	3 Qtrs
Fair value of derivative warrants issued to lenders in connection with issuance of subordinated promissory notes	`FairValueOfDerivativeWarrantsIssuedToLendersInConnectionWithIssuanceOfSubordinatedPromissoryNotes`	$83.36K	USD	3 Qtrs
Fair value of warrants issued in connection with deferred financing costs	`FairValueOfWarrantsIssuedInConnectionWithDeferredFinancingCosts`	-	USD	3 Qtrs
Fair value of warrants issued in connection with deferred financing costs	`FairValueOfWarrantsIssuedInConnectionWithDeferredFinancingCosts`	$41.68K	USD	3 Qtrs
Fair value of derivative warrants issued for offering costs in connection with the issuance of Series A preferred stock	`FairValueOfDerivativeWarrantsIssuedForOfferingCostsInConnectionWithTheIssuanceOfSeriesAPreferredStock`	-	USD	3 Qtrs
Fair value of derivative warrants issued for offering costs in connection with the issuance of Series A preferred stock	`FairValueOfDerivativeWarrantsIssuedForOfferingCostsInConnectionWithTheIssuanceOfSeriesAPreferredStock`	$163.62K	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.